Results of the work of the Military medical academy research institute of novel coronavirus infection problems through 2020–2021

Ivchenko, Evgeniy V.; Kotiv, Bogdan N.; Ovchinnikov, Dmitrii V.; Bucenko, Sergey A.

doi:10.17816/brmma83094

Cited by 19 publications

(3 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Многие медицинские учреждения России, в том числе Военно-медицинская академия имени С.М. Кирова (ВМедА), участвуют в оказании помощи больным с COVID-19 [1]. За 2021 г. в ВМедА было пролечено 56,1 % военнослужащих с этим диагнозом, 23,3 % пациентов по системе обязательного медицинского страхования, 20,5 % прочих льготных пациентов.…”

Section: оригинальные исследованияunclassified

Fighting SARS-CoV-2 infection: experience and prospects

Жданов¹,

Козлов²,

Maltsev³

et al. 2022

Russian Military Medical Academy Reports

View full text Add to dashboard Cite

BACKGROUND: COVID-19 is an international emergency. The Military Medical Academy, including the Department and Clinic of Infectious Diseases (with a course in medical parasitology and tropical diseases) are actively involved in the fight against the COVID-19 pandemic, and are also studying the pathogenesis, diagnosis and treatment of this disease. AIM: to systematize the work done at the Military Medical Academy in relation to the fight against a new coronavirus infection. MATERIALS AND METHODS: This article provides a brief description of the studies conducted in relation to COVID-19. RESULTS: The departments view of the infection caused by SARS-CoV-2 is presented, the main indicators of the work of the clinic of infectious diseases in the fight against COVID-19 are briefly reflected, and their own research in the field of this infectious disease is demonstrated. CONCLUSION: Based on our scientific work, our experience in treating patients with a new coronavirus infection, the main conclusions and recommendations are formulated: It is necessary to take into account the clinical feature of COVID-19 a long initial period (up to 8 days), which creates the illusion of imaginary well-being and contributes to late hospitalization. PCR is not an ideal diagnostic method, which creates the possibility of obtaining a false negative result. In this regard, clinical, epidemiological and radiological diagnostics are decisive. The organization of early active detection of patients with all clinical forms of infection caused by SARS-CoV-2, and their timely hospitalization helps to reduce the risk of developing a severe course, complications and epidemiological danger of patients. Complex antiviral and anticoagulant therapy should be early (up to 5 days from the clinical manifestation), proactive, aimed at reducing the likelihood of developing pneumonia with respiratory failure and thrombosis of the LA branches. Anti-inflammatory therapy increases the survival of patients with severe COVID-19 and should be administered as early as possible with a preventive goal at the first minimal clinical and laboratory signs of a hyperinflammatory response.

show abstract

Section: оригинальные исследованияunclassified

Fighting SARS-CoV-2 infection: experience and prospects

Жданов¹,

Козлов²,

Maltsev³

et al. 2022

Russian Military Medical Academy Reports

View full text Add to dashboard Cite

show abstract

“…Количество симптомов во время острой инфекции SARS-CoV-2, тяжесть заболевания и высокие уровни D-димера в сыворотке крови были связаны с высоким риском постковидного синдрома, который внесен в Международный классификатор болезней, код рубрики U09.9 «Состояние после COVID-19 неуточненное». Следует отметить, что он может существенно повлиять на состояние здоровья выживших пациентов [1][2][3].…”

Section: оригинальные исследованияunclassified

Rehabilitation of patients after a new coronavirus infection COVID-19 at the second and third stage

Kovlen¹,

Abuseva

Khoziainova

et al. 2022

Russian Military Medical Academy Reports

View full text Add to dashboard Cite

BACKGROUND: Patients who have undergone a COVID-19 infection are in need of comprehensive rehabilitation, taking the polysyndromic manifestations of the post- COVID syndrome and comorbidities into account. AIM: The purpose of this article is the need to evaluate the effectiveness of medical rehabilitation programs for patients who underwent a COVID-19 infection at the second and third stages of medical rehabilitation from the standpoint of evidence-based medicine. MATERIALS AND METHODS: 330 medical rehabilitation programs for patients who had a COVID-19 infection were examined. All patients underwent functional tests: control of blood oxygen saturation (SpO2), spirometry, Stange and Gench tests, testing on the Borg exercise tolerance scale and the MRC dyspnea scale; the EQ-5D quality of life questionnaire was completed. Patients were divided into 2 representative groups (160 and 170 people). The average duration of treatment was 14 days. The methods of physical and rehabilitation medicine: therapeutic exercises, breathing exercises, inhalation therapy were applied to the patients in the observation group. Patients in the observation group underwent rehabilitation treatment programs depending on comorbidities and severity of symptoms in organs and systems. The survey was conducted on at 2 control points: 1 day (first), 14 day (second). RESULTS: The observation group showed significantly better recovery results (p 0.05). The average values of the Stange and Gench samples showed a positive trend. There was an improvement in the subjective assessment of the tolerability of the 6-minute walk test on the Borg scale, a decrease in the severity of dyspnea on the MRC dyspnea scale, and an improvement in the quality of life on the EQ-5D scale. CONCLUSION: The structure of the rehabilitation programs used in the clinic of medical rehabilitation and recovery treatment was analysed, showing positive results that have indicated the effectiveness of the methods of physical and rehabilitation medicine in patients with various manifestations of post-COVID syndrome.

show abstract

“…According to the website стопкоронавирус.рф and the MMA freelance Research Institute of Novel Coronavirus Infection Problems [ 1 , 2 ], the recorded number of people infected with SARS-CoV-2 around the world continues to increase; the number relative to the population of the country is, for example, about 14% in the United States, about 10% in Brazil, and no more than 5% in Russia, while in the Armed Forces of the Russian Federation this figure is about 1% and is associated primarily with replacements 2 times a year.…”

mentioning

confidence: 99%

Experience of Military Medicine in the Fight against the New Coronavirus Infection

Kryukov

Trishkin²,

Салухов³

et al. 2022

Her. Russ. Acad. Sci.

View full text Add to dashboard Cite

The results achieved by the medical service of the Armed Forces of the Russian Federation to overcome the new coronavirus infection are presented. The high efficiency of the established unified system of biological safety and strict ranking of the priorities of anti-epidemic measures is shown. The experience of organizing traveling medical and nursing teams, as well as temporary military medical units on the territory of Russia, as well as in foreign countries, is demonstrated. Among the priority scientific results of military doctors, especially noteworthy is the study of the world’s first COVID-19 vaccine Sputnik V, its immunogenicity, the effectiveness of its use in previously ill patients and revaccination, as well as the use of immune plasma from those who have been ill and vaccinated. By the examples of organized military groups and the general population, the features of the formation of herd immunity have been studied. Military doctors were the first in the country to show the effectiveness of hormone therapy in the treatment of coronavirus infection and to study its effects. They carried out ultrastructural studies of the life cycle of the virus. It is shown that the system of comprehensive measures implemented by military medicine determined a lower incidence of new coronavirus infection among the personnel of the Ministry of Defense of Russia and a lower mortality among the military.

show abstract

Results of the work of the Military medical academy research institute of novel coronavirus infection problems through 2020–2021

Cited by 19 publications

References 46 publications

Fighting SARS-CoV-2 infection: experience and prospects

Fighting SARS-CoV-2 infection: experience and prospects

Rehabilitation of patients after a new coronavirus infection COVID-19 at the second and third stage

Experience of Military Medicine in the Fight against the New Coronavirus Infection

Contact Info

Product

Resources

About